author-photo

Luc van Rompaey

9

Papers

672

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial

2018 Blood
Show All
- Source
- Cite
- Save
Citations (10)
Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (23)
ARGX-111 shows activity in MET-amplified patients in a phase-I study and in preclinical models of myeloid-derived suppressor cell (MDSC) depletion in the tumor microenvironment.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Clinical response observed in a phase I study in T cell lymphoma patients treated with anti-CD70 SIMPLE antibody ARGX-110

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.

2000 Molecular and Cellular Biology
Show All
- Source
- Cite
- Save
Citations (93)
Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6.

2000 Blood
Show All
- Source
- Cite
- Save
Citations (62)
Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia

1997 Blood
Show All
- Source
- Cite
- Save
Citations (466)
Separation of some metabolically important aromatic nacylamino acids of the benzoyl and cinnamoyl series by thin-layer, gas—liquid and high-performance liquid chromatography

1982 Journal of Chromatography A
Show All
- Source
- Cite
- Save
Citations (11)